Zinc complex with quinoline-based thiazolyl-hydrazone targeting DNA replication in cancer cells.

ABSTRACT: The development of selective anticancer agents remains a central objective in medicinal chemistry. Here, we report the synthesis, structural characterization, and biological evaluation of the first metal complex of a quinoline-based thiazolyl-hydrazone ligand [(E)-2-(8-(quinolin-2-ylmethylene)hydrazinyl)-4-(4-tolyl)-1,3-thiazole)] (HL). Obtained octahedral Zn(II) complex [Zn(HL)₂](NO₃)₂, (1), is based on two NNN tridentate coordinated ligands. In vitro cytotoxicity assays revealed that the complex exhibits potent and selective activity against lung adenocarcinoma A-549 and colorectal carcinoma HCT-116, while sparing non-tumorigenic human embryonic kidney HEK-293 cells. Mechanistic studies demonstrated that the complex induces S-phase arrest, inhibits DNA sy

SUBMITTER: Maciejewska N 

PROVIDER: S-EPMC12663193 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature